Tag: Food & Drug Administration
FDA Approves Mavyret for Hepatitis C
Combo drug is first approved therapy for hepatitis C to require as few as eight weeks of treatment
FDA Approves New Treatment for Acute Myeloid Leukemia
Vyxeos combines two previously approved drugs -- daunorubicin and cytarabine
FDA Approves Idhifa for Some With Acute Myeloid Leukemia
For adults with relapsed or refractory AML who have an IDH2 genetic mutation
FDA Approves Imbruvica to Treat Chronic Graft Versus Host Disease
Drug sanctioned for patients with cGVHD who do not respond to other forms of therapy
FDA Proposes Lowering Nicotine Levels in Cigarettes
Goal is to combat smoking by making it less addictive
FDA Approves First Neonatal MRI Device
Device designed for neonatal brain and head imaging in intensive care units
FDA Approves Nerlynx to Help Prevent HER2+ Breast CA Return
Drug is a kinase inhibitor that works by blocking several enzymes that promote cell growth
Potential First U.S. Gene Therapy Now Under FDA Review
Tisagenlecleucel could be a one-time treatment for children and young adults with advanced leukemia
FDA Approves Endari for the Treatment of Sickle Cell Disease
First treatment approved for patients with sickle cell disease in almost 20 years
FDA Expands Use of Cooling Cap to Cut Chemo-Related Hair Loss
Treatment now approved for patients receiving chemotherapy for solid tumors
